Cobalamin deficiency in primary care: a placebo-controlled, double-blind, randomized trial
Completed
- Conditions
- Cobalamin deficiencyNutritional, Metabolic, Endocrine
- Registration Number
- ISRCTN22063938
- Lead Sponsor
- Medical Outpatient Clinic, University of Lausanne (Switzerland)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Patients suspected of cobalamin deficiency with serum vitamin B12 level between 125 and 200 pmole/l. Patients with serum vitamin B12 level below 125 pmole/l were followed-up openly with oral cobalamin.
Exclusion Criteria
Unwillingness to participate
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Evolution of biological markers (serum vitamin B12 level, serum methymalonic acid and homocystein levels)
- Secondary Outcome Measures
Name Time Method Clinical evolution (hematologic, neurologic, psychiatric)